TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors.

Autor: Chang GA; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, NYU Langone Health, New York, USA; The Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, NYU Langone Health, New York, USA; St. Georges University School of Medicine, Grenada, West Indies., Wiggins JM; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, NYU Langone Health, New York, USA; The Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, NYU Langone Health, New York, USA., Corless BC; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, NYU Langone Health, New York, USA; The Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, NYU Langone Health, New York, USA; Weill Cornell Medicine Graduate School of Medical Sciences, New York, USA., Syeda MM; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, NYU Langone Health, New York, USA; The Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, NYU Langone Health, New York, USA., Tadepalli JS; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, NYU Langone Health, New York, USA; The Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, NYU Langone Health, New York, USA., Blake S; MolecularMD Corporation, Portland, Oregon, USA., Fleming N; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, NYU Langone Health, New York, USA; The Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, NYU Langone Health, New York, USA., Darvishian F; The Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, NYU Langone Health, New York, USA; Department of Pathology, New York University School of Medicine, NYU Langone Health, New York, USA., Pavlick A; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, NYU Langone Health, New York, USA; The Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, NYU Langone Health, New York, USA; Division of Medical Oncology, Department of Medicine, New York University School of Medicine, NYU Langone Health, New York, USA., Berman R; The Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, NYU Langone Health, New York, USA; Department of Surgery, New York University School of Medicine, NYU Langone Health, New York, USA., Shapiro R; The Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, NYU Langone Health, New York, USA; Department of Surgery, New York University School of Medicine, NYU Langone Health, New York, USA., Shao Y; The Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, NYU Langone Health, New York, USA; Department of Population Health, New York University School of Medicine, NYU Langone Health, New York, USA., Karlin-Neumann G; Bio-Rad Laboratories, Hercules, California, USA., Spittle C; MolecularMD Corporation, Portland, Oregon, USA., Osman I; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, NYU Langone Health, New York, USA; The Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, NYU Langone Health, New York, USA; Division of Medical Oncology, Department of Medicine, New York University School of Medicine, NYU Langone Health, New York, USA., Polsky D; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, NYU Langone Health, New York, USA; The Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, NYU Langone Health, New York, USA. Electronic address: david.polsky@nyumc.org.

Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2020 Aug; Vol. 140 (8), pp. 1609-1618.e7. Date of Electronic Publication: 2020 Feb 20.

Development and Evaluation of a Framework for Authentic Online Co‐Design: Partnership‐Focussed Principles‐Driven Online Co‐Design.

Autor: Coulston, Free^1,2 free.coulston@unimelb.edu.au, Spittle, Alicia^1,2,3, McDonald, Cassie^1,4, Toovey, Rachel^1,2, Cameron, Kate L.^1,2, Attard, Kimberley¹, Binstock, Loni^1,5, Fletcher, Isaac¹, Delaney, Adie¹, Murphy, Tayla¹, Keating, Caroline¹, Sellick, Kath¹

Publikováno v: Health Expectations. Aug2024, Vol. 27 Issue 4, p1-13. 13p.

Cost Effective Security Progression from Unclassified to System High to Multi-Level Security.

Autor: Edington, J. E., Spittle, C. W., Skarphol, J. C., Tubbs, E. C.

Publikováno v: ITEA Journal of Test & Evaluation; Jun2016, Vol. 37 Issue 2, p181-190, 10p

Real-Time Reverse-Transcription Quantitative Polymerase Chain Reaction Assay Is a Feasible Method for the Relative Quantification of Heregulin Expression in Non-Small Cell Lung Cancer Tissue.

Autor: Kristof J; Clinical Assay Development, MolecularMD, Portland, OR, USA.; Phylos Bioscience, Portland, OR, USA., Sakrison K; Clinical Assay Development, MolecularMD, Portland, OR, USA.; ARUP Laboratories, Salt Lake City, UT, USA., Jin X; Biostatistics and Data Management, Daiichi Sankyo Pharma Development, Edison, NJ, USA.; MedImmune, Gaithersburg, MD, USA., Nakamaru K; Translational Medicine and Clinical Pharmacology, Daiichi Sankyo Co., Ltd., Tokyo, Japan., Schneider M; Preclinical and Pharmacology, U3 Pharma GmbH, Martinsried, Germany., Beckman RA; Departments of Oncology and of Biostatistics, Bioinformatics & Biomathematics, Georgetown Lombardi Comprehensive Cancer Center and Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Georgetown University, Washington, DC, USA., Freeman D; MedImmune, Gaithersburg, MD, USA.; Translational Medicine and Clinical Pharmacology, Daiichi Sankyo Pharma Development, Edison, NJ, USA., Spittle C; Clinical Assay Development, MolecularMD, Portland, OR, USA., Feng W; Translational Medicine and Clinical Pharmacology, Daiichi Sankyo Pharma Development, Edison, NJ, USA.

Publikováno v: Biomarker insights [Biomark Insights] 2017 Mar 30; Vol. 12, pp. 1177271917699850. Date of Electronic Publication: 2017 Mar 30 (Print Publication: 2017).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.